You are here

Endocrine

Bottom Line: Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to data from a meta-analysis.

Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

New research demonstrating the clinical utility of Bio-Rad's Droplet Digital PCR (ddPCR) powered liquid biopsy will be presented this week during the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta, March 29-April 3. Many of the studies rely on the sensitivity, speed, and cost-effectiveness of ddPCR technology to measure blood-based tumor biomarkers in a reproducible way.

People who take replacement thyroid hormone may have more comorbidities and lower quality of life than those who don't take the hormone, a large population-based study from the University of Groningen in the Netherlands reports. The study results will be presented Tuesday, March 20, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill.

Hypothyroidism is a common disorder, and replacement therapy with levothyroxine (LT4) is the standard treatment.

Essential oils are oils with a characteristic flavour or odour. They have become popular in recent years as alternative medicines and additives in personal hygiene and cleaning products. However, a new study that has found lavender and tea tree oil could cause abnormal breast growth in young boys.

 

While they are commonly seen as beneficial at best and harmless at worst, there is a growing body of evidence that some essential oils can actually have negative health impacts.

The heart-healthy Mediterranean diet also appears to be good for an older woman's bones and muscles, a new study of postmenopausal women in Brazil finds. The study results will be presented Monday at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago, Ill.

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care.

The findings, reported in JAMA Surgery, are the first comprehensive nationwide population-based study regarding the need for breast biopsies performed during follow up after treatment for invasive breast cancer.

Subscribe to Endocrine